-
India Inc's profits relative to capital employed at 14-yr high
22 Dec 2025 09:36 GMT
… Deepak Jasani.
Till the second quarter (July-September) this … the second quarter, sales growth picked up pace and profitability improved, … oriented ones like the pharmaceutical sector.
The outlook for … manufacturing, which saw profit after tax relative to …
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
22 Dec 2025 08:45 GMT
… close in the second quarter of 2026, … (Amicus) by BioMarin Pharmaceutical Inc. (BioMarin) (Transaction), … Faughnan, Investors
BioMarin Pharmaceutical Inc.
Amicus Therapeutics
… revenue-growth-and-strengthening-financial-outlook-302646880.html
SOURCE BioMarin Pharmaceutical …
-
BioMarin makes its largest-ever transaction, paying $4.8B for fellow rare disease drugmaker Amicus
19 Dec 2025 18:29 GMT
… deal will accelerate BioMarin’s revenue growth immediately upon close, … soon face competition from Ascendis Pharma';s TransCon CNP, … of the year after the drugmaker gained Inozyme for $270 million … Amicus to close in the second quarter of next year.
-
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
19 Dec 2025 17:25 GMT
… straight quarter.
Nike posted second-quarter revenue of $12.43 billion, … Pro. The company reported second-quarter earnings of 53 cents … acquired by BioMarin.
Biomarin Pharmaceutical Inc (NASDAQ:BMRN) shares … to $44.70 following second-quarter results.
Shares of …
-
FedEx Corporation (NYSE:FDX) Q2 2026 Earnings Call Transcript
19 Dec 2025 13:09 GMT
… s Second Quarter Earnings Conference Call.
Jenifer Hollander: The second quarter … reduce inefficiencies and increase profitability. Additionally, it provides … lower than Q2. We expect revenue sequentially to … really important to the pharma segment. That is …
-
Tatva Chintan Pharma Chem: Specialty Chemicals Play Poised for Recovery after Downcycle
19 Dec 2025 11:52 GMT
… pharmaceuticals/;active pharmaceutical ingredients (APIs, specialty chemicals, agrochemicals and electrolyte salts diversifies revenue … overall profitability by … Q2 FY25-26 Performance
Tatva reported consolidated operating revenue … pharmaceuticals and …
-
MillerKnoll, Inc. (NASDAQ:MLKN) Q2 2026 Earnings Call Transcript
18 Dec 2025 13:07 GMT
… opening four new locations in Q2, a DWR in Salt Lake … to execute our growth strategy. Second quarter consolidated gross margin was a … bit of an impact And pharma and banking are down slightly … new stores begin to add revenue to really offset that investment …
-
Sun Pharma share price falls 3% after US FDA conducts inspection in Baska facility. Should you buy, sell or hold?
18 Dec 2025 07:53 GMT
… status.
Sun Pharma Q2 results 2025
Sun Pharma reported a 2 … ,291 crore in Q2 FY25.
Operating profit (EBITDA) rose sharply … the corresponding quarter.
Sun Pharma share price: Should you … Lupin and Sun Pharmaceutical Industries’ India revenue, which grew strongly …
-
BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition
19 Dec 2025 20:11 GMT
… BioMarin Pharmaceutical is buying its way to revenue growth … indication from Ascendis Pharma and BridgeBio Pharma is putting pressure … immediately accelerate BioMarin’s revenue growth, Leerink Partners … the transaction in the second quarter of 2026.
Photo: …
-
Today-History-Dec20
20 Dec 2025 09:34 GMT
… an agreement to share tax revenues.
In 1982, Wayne Gretzky became … game. He left in the second-quarter against Chicago after suffering a … , including aviation and space and pharmaceutical technology.
In 2020, Ottawa began …
About
© 1995-2025